Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer

(MedPage Today) -- Amid an ongoing investigation of CAR T-cell therapy safety, the FDA has added risk of secondary malignancies to the boxed warning for ciltacabtagene autoleucel (Carvykti). (Fierce Pharma) Cellular and gene therapy will likely...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news